Recipharm Working With Transpire Bio to Develop Inhaled Medicine
TRB-1 and TRB-2, the first products developed by Transpire Bio, will be indicated for the treatment of asthma and COPD, intended for advanced markets.
Source: healthcarepackaging.com
Stay updated with breaking news from Transpire Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TRB-1 and TRB-2, the first products developed by Transpire Bio, will be indicated for the treatment of asthma and COPD, intended for advanced markets.
Under the agreement, Recipharm will help advance two inhaled medicines intended for asthma and chronic obstructive pulmonary disease (COPD).